Cargando…

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”

Detalles Bibliográficos
Autores principales:	Ding, Ze-yang, Li, Gan-xun, Shu, Chang, Yin, Ping, Zhang, Bixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180345/ https://www.ncbi.nlm.nih.gov/pubmed/34090927 http://dx.doi.org/10.1016/j.jhep.2021.05.027

Ejemplares similares

Association of liver abnormalities with in-hospital mortality in patients with COVID-19
por: Ding, Ze-yang, et al.
Publicado: (2021)

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Author reply to comments
por: Bhalla, Ashu Seith, et al.
Publicado: (2015)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

Reply: Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality'
por: McCormack, V, et al.
Publicado: (2013)

Reply to comment of Prof. Artur Czekierdowski
por: Jakiel, Grzegorz
Publicado: (2017)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection”
por: Covino, Marcello, et al.
Publicado: (2022)

Author’s Reply: Comments on “Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses”
por: Liu, Mou-Ze, et al.
Publicado: (2017)

Reply to comment on “COVID-19 incidence and hospitalization during the delta surge were inversely related to vaccination coverage”
por: Harris, Jeffrey E.
Publicado: (2022)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Redefining vitamin D deficiency: Reply to comments
por: Garg, MK, et al.
Publicado: (2014)

Reply to Comment on: Fungal keratitis: The Aravind Experience
por: Prajna, Venkatesh N, et al.
Publicado: (2018)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’
por: Waked, Iman, et al.
Publicado: (2017)

Reply: Comment on ‘Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies'
por: Lu, Z, et al.
Publicado: (2014)

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
por: Ji, Dong, et al.
Publicado: (2021)

Reply to Comments on Relationship between Hypoalbuminemia on Admission and Long-term Mortality in Patients with Acute Decompensated Heart Failure
por: Yatsu, Shoichiro, et al.
Publicado: (2019)

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Johnson, Philip, et al.
Publicado: (2016)

Comment on: Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
por: Zhang, Han, et al.
Publicado: (2023)

Reply to comment: Conventional manual small-incision cataract surgery
por: Yang, Jun, et al.
Publicado: (2015)

Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
por: Williams, Gwyn Samuel, et al.
Publicado: (2014)

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

In Reply to “The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad”
por: Imasawa, Toshiyuki, et al.
Publicado: (2022)

Reply to: “Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review””
por: Grønkjær, Lea Ladegaard, et al.
Publicado: (2021)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Comment on: Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19
por: Mahfooz, Kamran
Publicado: (2023)

Comment on: An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)
por: Liu, Zhi-Peng, et al.
Publicado: (2023)

Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030'
por: Ahmad, A S, et al.
Publicado: (2013)

Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'
por: Alvarez, R, et al.
Publicado: (2014)

Authors’ Reply: Comment to Varied phenotype of Homocystinuria: Possible diagnostic error
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Author reply to comment on subconjunctival limbus oblique incision for mature cataracts
por: Yang, Jun, et al.
Publicado: (2015)

Author’s reply to ‘Rickettsia retinitis cases in India: a few comments’
por: Kawali, Ankush A., et al.
Publicado: (2016)

Authors' Reply to Comments on the Association between Workplace Environment and Metabolic Syndrome
por: Soo Jeong, Hwee
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4bolvcq753spf3ri7p7t3se1ht